NF2 and cancer: Although recent studies have reported that some mutations of YAP, Lats1/2, GPCRs, NF2, and TAZ are related to the development of cancer [105], it is still unclear why the mutations in Hippo signaling pathway genes are so rare, when considering that YAP and TAZ activation is so frequently observed in a broad range of human cancers.